Pancreatic Cancer Research

Clinical trialNo phase (not a drug trial)Active not recruiting

Progressive Muscle Relaxation Exercises on Sleep, Fatigue and Pain in Pancreatic and Colon Cancer Patients

Effects of Progressive Muscle Relaxation Exercises on Sleep, Fatigue and Pain in Pancreatic and Colon Cancer Patients Receiving Chemotherapy

NCT06920082↗ ClinicalTrials.gov, retrieved 6 November 2026

Outcome
Ongoing
Phase
No phase (not a drug trial)
Status
Active not recruiting
Study type
Interventional
Start
3 March 2025
Listed end
31 July 2025
Enrollment
60 participants
Sites
1
Primary outcomes
Visual Analog Scale; Visual Analog Scale; The Piper Fatigue Scale; The Piper Fatigue Scale
Sponsor type
Academic / other
Results posted
No
Last update
9 April 2025

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

With regular practice, relaxation has been found to have many benefits such as reducing sensitivity to pain and fatigue, facilitating the transition to sleep, and improving quality of life. Therefore, this study was planned to examine the effects of progressive muscle relaxation exercises applied to pancreatic and colon cancer patients receiving chemotherapy on sleep, fatigue, and pain.

Detailed description public domain (ClinicalTrials.gov)

A total of 18 sessions of progressive relaxation were performed, 3 days a week for 6 weeks.

Papers 2